Nirogy Therapeutics is focusing on small-molecule drugs that target the solute carrier family of transporter proteins (SLCTs). Founded in 2013, Nirogy Therapeutics is backed by investors that include Sporos Bioventures and Sante Ventures and is headquartered in Natick.
FOUNDED:
2013
INDUSTRY:
Biopharma, Biotechnology, Pharmaceutical
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
